KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Coronavirus

Daewoong to Begin Trial of COVID-19 Stem Cell Treatment in Indonesia

 1,820 total views,  1 views today

James Jung by James Jung
PUBLISHED: July 6, 2020 UPDATED: July 6, 2020
in Coronavirus, Daewoong Pharnaceuticals, Healthcare, Indonesia, Virus
0
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.

Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.

Daewoong Pharmaceutical, a South Korean bioengineering company, stated on Monday that it would conduct phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.

Jeon Seung-ho, Daewoong CEO, said that the company aims to fast track the development of the drug to make it available in the market as soon as possible.

The Indonesian Health Ministry works closely with Daewoong Infion, the Indonesian arm of Daewoong Pharmaceutical, in researching the efficacy of DWP710 (mesenchymal stem cell) in the treatment of the coronavirus. Daewoong would move to the next phase of testing in South Korea this 2020 if it establishes the potency of DWP710 in phase 1.

Korea’s revised bio law states that health specialists can grant provisional approval for drugs that have completed phase 2 clinical trials to speed up their use in hospitals battling COVID-19.

Mesenchymal stem cells could be classified into a range of cell forms comprising cartilage cells, fat cells, bone cells, and muscle cells which provide marrow adipose tissue. The mesenchymal cells contain a great capacity for cell renewal while sustaining their efficacy and potency.

The mesenchymal stem cells provided anti-inflammatory and antiviral effects in testing animals with the acute respiratory syndrome. Daewoong confirmed these effects with an increased survival rate of 30 percent, and a close to full-recovery of damaged lung tissue in the test group.

The company presented a cell banking system where patients can immediately acquire frozen stem cells stored in hospitals.

Daewoong stated that they achieved progress in the first animal testing using niclosamide (DWRX2003). Niclosamide is a treatment medicine for tapeworms chosen for COVID-19 antibody treatment.

Institut Pasteur Korea, a research institute for infectious diseases, initiated a joint research task with Daewoong Therapeutics to examine the efficacy of niclosamide (DWRX2003). Niclosamide works by starving tapeworms to death.

What’s your thoughts?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: clinical trialCOVID-19Daewoon PharmaceuticalsDaewoongIndonesiaphase 1stem celltreatment

Related Posts

GC Biopharma to launch first-in-class rare disorder medications in the global market
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Healthcare

GC Biopharma to launch first-in-class rare disorder medications in the global market

March 2, 2023
INTIN introduces new digital healthcare products to improve quality of life
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Healthcare

INTIN introduces new digital healthcare products to improve quality of life

November 27, 2021
Intin, a digital healthcare startup, honored with the ‘CES Innovation Award’ for technological prowess in healthcare
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Healthcare

Intin, a digital healthcare startup, honored with the ‘CES Innovation Award’ for technological prowess in healthcare

November 20, 2021
Celltrion pushes for broader use of its COVID-19 treatment 
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Celltrion

Celltrion pushes for broader use of its COVID-19 treatment 

August 12, 2021
Hyundai Mobis presented M.Brain, the world’s first in-vehicle brainwave measuring healthcare technology, reducing drowsiness-caused vehicular accidents.
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Healthcare

Hyundai Mobis Unveils World’s 1st In-Vehicle Brainwave Tech M.Brain

July 24, 2021
SK’s drug-making unit SK Biopharmaceuticals revealed its target to become one of the world’s market-leading healthcare technology developers and providers.
Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.
Healthcare

SK’s Drug Maker Unit to Become a Globally Leading Healthcare Firm

July 6, 2021
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • Robots to help Police Patrol in South Korea

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • South Korea plans Urban Air Mobility Air Taxi services by 2025

    0 shares
    Share 0 Tweet 0
  • SK On to introduce South Korea’s first LFP Battery Prototype

    0 shares
    Share 0 Tweet 0
  • South Korea to commercialize Quantum Cryptography Communications

    0 shares
    Share 0 Tweet 0
  • Top Eight Promising EdTech Startup Companies in South Korea

    0 shares
    Share 0 Tweet 0
  • Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut

    0 shares
    Share 0 Tweet 0
  • Nexon To Reorganize Amid Failing Profits

    0 shares
    Share 0 Tweet 0
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Newsletter
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |